The Impact Of Price Regulation On The Availability Of New Drugs In Germany

Author:

Stern Ariel D.1,Pietrulla Felicitas2,Herr Annika3,Kesselheim Aaron S.4,Sarpatwari Ameet5

Affiliation:

1. Ariel D. Stern () is an associate professor of business administration and a Hellman Faculty Fellow in the Department of Technology and Operations Management, Harvard Business School, in Boston, Massachusetts.

2. Felicitas Pietrulla is a student in the Harvard Program in Therapeutic Science, Harvard Medical School, in Boston.

3. Annika Herr is a professor in the Institute of Health Economics, Leibniz University Hannover, in Germany, and a research affiliate in the Department of Economics, Heinrich Heine University Düsseldorf, in Germany.

4. Aaron S. Kesselheim is a professor of medicine at Harvard Medical School and director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, both in Boston.

5. Ameet Sarpatwari is an instructor in medicine at Harvard Medical School and assistant director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3